CVHB937A12201 Study (Novartis)
The CVHB937A12201 Study is looking to find out more about an investigational medication (called a study drug) in people with mild AD. We want to look at the study drug […]
Closed to recruitment
All clinical trials
DFP: Deep and Frequent Phenotyping: Combinatorial Biomarkers for Dementia Experimental Medicine
The DFP study aims to create a database of different measures taken by people at risk of Alzheimer’s disease. The measures include regular brain scans, cognitive and memory tests, scans […]
Closed to Recruitment
ISAP: Impact of Semaglutide in Amyloid Positivity: The ISAP Proof of Concept Study
The ISAP Study led in collaboration between the Diabetes Trial Unit and the Department of Psychiatry at the University of Oxford and Novo Nordisk will examine whether semaglutide, a tablet […]
Closed to Recruitment
ReTain
Alzheimer’s disease begins long before symptoms show. The ReTain study is evaluating whether an investigational medication is safe, tolerable and effective at slowing the onset of Alzheimer’s disease symptoms for […]
Closed to recruitment
WN45447 Study (Trontier 2)
The WN45447 study aims to determine if an experimental drug can help slow down Alzheimer’s disease. WN45447 will include approximately 800 adults who have a recent diagnosis of mild cognitive […]
Closed to recruitment
